AMD has cleared regulatory hurdles everywhere but China. News filtered out earlier this month that AMD has filed certain undefined 'behavioural remedies' to appease Chinese regulators, and mid-month found news that China's antitrust agency, the State Administration for Market Regulation (SAMR), was still market-testing AMD's proposed remedies.
In an official statement the company said: "We continue making satisfactory progress on the required regulatory approvals to close our transaction. While we had previously expected that we would secure all approvals by the end of 2021, we have not yet completed the process and we now expect the transaction to close in the first quarter of 2022. Our conversations with regulators continue to progress productively, and we expect to secure all required approvals. There are no additional changes to the previously announced terms or plans regarding the transaction and the companies continue to look forward to the proposed combination creating the industry's high-performance and adaptive computing leader."